Steroid Stewardship in COVID-19.
J Nepal Health Res Counc
; 19(3): 631-634, 2021 Dec 15.
Article
in English
| MEDLINE | ID: covidwho-1687867
ABSTRACT
Corticosteroids have transformed clinical practice in COVID-19 following the publication of the results of the RECOVERY trial. Despite available evidence, there is considerable disparity among physicians in the dose and duration of steroids they prescribe. Steroids have a fragile affiliation in clinical practice with the benefits frequently accompanied by distressing adverse effects. An institutional steroid stewardship program can help all physicians take advantage of what is the only proven therapy of benefit in this global crisis while avoiding its overuse and the numerous adverse effects associated with it. Keywords COVID-19; corticosteroids; RECOVERY trial; steroid stewardship.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
J Nepal Health Res Counc
Journal subject:
Health Services Research
Year:
2021
Document Type:
Article
Affiliation country:
Jnhrc.v19i3.3660
Similar
MEDLINE
...
LILACS
LIS